William Ilua Muasya
Supervisors
Dr. Melissa Kapulu
Dr. Melissa Kapulu
Email : MKapulu@kemri-wellcome.org Melissa attended the University of Zambia (199-2004) where she undertook a BSc in Molecular biology and genetics. Upon receipt of a Commonwealth Scholarship, Melissa moved to London where she read for an MSc in Immunology of Infectious Diseases (2006-2007), at the London School of Hygiene and Tropical Medicine. In 2007, she moved back to Zambia and worked at the University of Zambia (Biological Sciences Department and School of Medicine) and in addition, worked in Paul Kelly’s lab, looking at oral immune responses to vaccination (Tropical Gastroenterology & Nutrition Group) (2007-2009). In 2009, she received further Commonwealth Scholarship funding for DPhil research on malaria transmission-blocking vaccines in Adrian Hill’s lab, Jenner Institute, University of Oxford (2009-2014). In May of 2013, Melissa took up a post-doctoral position with Kevin Marsh at the KEMRI-Wellcome Trust Research Programme in Kilifi working on assessing the infectious reservoir of malaria. Her main interests are in understanding immunological aspects of malaria transmission with the aim of identifying and developing vaccine candidate targets.
William has always been fascinated by how the human body works, as well as utilizing technology to improve medical research. This inspired him to pursue Medical biotechnology with Information Technology at Maseno University. In 2018, he completed a Post Graduate Diploma program in Health Research Methods at Pwani University in collaboration with Kemri-Wellcome Trust where he was working on the kinetics of gametocyte expression in individuals undergoing controlled human malaria infection (CHMI).
His interests lie in understanding the immunology of infectious tropical disease and vaccine development. Currently, William is an MSc Immunology student at Pwani University and doing his project at KWTRP. He seeks to identify novel antigens on the surface of gametocyte-infected erythrocytes that could be utilized as transmission-blocking vaccines in malaria.
- 51
- 66
- 48
- 104
- 44
- 423